HK1131058A1 - Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors - Google Patents
Nitrogen containing substituted heterocycles as platelet adp receptor inhibitorsInfo
- Publication number
- HK1131058A1 HK1131058A1 HK09110735.0A HK09110735A HK1131058A1 HK 1131058 A1 HK1131058 A1 HK 1131058A1 HK 09110735 A HK09110735 A HK 09110735A HK 1131058 A1 HK1131058 A1 HK 1131058A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nitrogen containing
- receptor inhibitors
- containing substituted
- substituted heterocycles
- adp receptor
- Prior art date
Links
- 102000007466 Purinergic P2 Receptors Human genes 0.000 title 1
- 108010085249 Purinergic P2 Receptors Proteins 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84632806P | 2006-09-20 | 2006-09-20 | |
| US11/856,616 US7834023B2 (en) | 2006-09-20 | 2007-09-17 | Substituted dihydroquinazolines as platelet ADP receptor inhibitors |
| PCT/US2007/079076 WO2008036843A2 (en) | 2006-09-20 | 2007-09-20 | Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1131058A1 true HK1131058A1 (en) | 2010-01-15 |
Family
ID=39048759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09110735.0A HK1131058A1 (en) | 2006-09-20 | 2009-11-17 | Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7834023B2 (de) |
| EP (1) | EP2094272B1 (de) |
| JP (1) | JP5266232B2 (de) |
| KR (1) | KR20090057314A (de) |
| AU (1) | AU2007299723A1 (de) |
| BR (1) | BRPI0718444A2 (de) |
| CA (1) | CA2664411A1 (de) |
| CO (1) | CO6160324A2 (de) |
| HK (1) | HK1131058A1 (de) |
| IL (1) | IL197726A0 (de) |
| MA (1) | MA30775B1 (de) |
| MX (1) | MX2009003017A (de) |
| NO (1) | NO20091331L (de) |
| NZ (1) | NZ576162A (de) |
| RU (1) | RU2009114827A (de) |
| TN (1) | TN2009000091A1 (de) |
| WO (1) | WO2008036843A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100260825A1 (en) * | 2009-04-13 | 2010-10-14 | Nair Madhavan G | Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches |
| BR112013033316A2 (pt) | 2011-06-24 | 2017-01-31 | Amgen Inc | antagonista de trpm8 e seu uso em tratamentos |
| EP2723718A1 (de) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8-antagonisten und ihre verwendung bei behandlungen |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| JP6243908B2 (ja) | 2012-08-23 | 2017-12-06 | アリオス バイオファーマ インク． | パラミクソウイルス感染症を治療するための化合物 |
| PE20180500A1 (es) | 2015-06-26 | 2018-03-09 | Takeda Pharmaceuticals Co | Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores del receptor muscarinico colinergico m1 |
| WO2017069173A1 (ja) | 2015-10-20 | 2017-04-27 | 武田薬品工業株式会社 | 複素環化合物 |
| EP3787626B1 (de) * | 2018-04-30 | 2023-06-07 | Unity Biotechnology, Inc. | Phosphonamidate als antagonisten der bcl-familie zur verwendung beim klinischen management von erkrankungen, die durch seneszente zellen verursacht oder vermittelt werden, sowie zur behandlung von krebs |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL135175B2 (en) * | 1983-12-22 | 1985-10-31 | Method of printing of articles made of polyamide fibres | |
| DE19650975A1 (de) * | 1996-12-09 | 1998-06-10 | Basf Ag | Neue heterocyclisch substituierte Benzamide und deren Anwendung |
| CZ300293B6 (cs) | 1999-03-17 | 2009-04-15 | Astrazeneca Ab | Nové amidové deriváty, zpusob jejich prípravy a farmaceutická kompozice, která je obsahuje |
| US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
| FR2837201A1 (fr) * | 2002-03-18 | 2003-09-19 | Servier Lab | Nouveaux composes derives de la quinazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2005097276A (ja) * | 2003-08-22 | 2005-04-14 | Takeda Chem Ind Ltd | 縮合ピリミジン誘導体およびその用途 |
| KR20060113699A (ko) * | 2003-10-03 | 2006-11-02 | 포톨라 파마슈티컬스, 인코포레이티드 | 치환된 이소퀴놀리논 |
| AU2004278030C1 (en) | 2003-10-03 | 2010-12-02 | Portola Pharmaceuticals, Inc. | 2,4-Dioxo-3-quinazolinylaryl sulfonylureas |
| CA2568756A1 (en) | 2004-06-15 | 2005-12-29 | Astrazeneca Ab | Substituted quinazolones as anti-cancer agents |
| US20070010537A1 (en) * | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
| CN101031565B (zh) | 2004-09-29 | 2010-09-29 | 博尔托拉制药公司 | 取代的2h-1,3-苯并噁嗪-4(3h)-酮 |
| JP2009541310A (ja) | 2006-06-19 | 2009-11-26 | アストラゼネカ・アクチエボラーグ | イソキノリン誘導体およびサイトカイン仲介疾患の阻害剤としてのそれらの使用 |
-
2007
- 2007-09-17 US US11/856,616 patent/US7834023B2/en not_active Expired - Fee Related
- 2007-09-20 MX MX2009003017A patent/MX2009003017A/es active IP Right Grant
- 2007-09-20 NZ NZ576162A patent/NZ576162A/en not_active IP Right Cessation
- 2007-09-20 BR BRPI0718444-1A2A patent/BRPI0718444A2/pt not_active IP Right Cessation
- 2007-09-20 KR KR1020097007782A patent/KR20090057314A/ko not_active Application Discontinuation
- 2007-09-20 RU RU2009114827/15A patent/RU2009114827A/ru not_active Application Discontinuation
- 2007-09-20 AU AU2007299723A patent/AU2007299723A1/en not_active Abandoned
- 2007-09-20 EP EP07842909.9A patent/EP2094272B1/de active Active
- 2007-09-20 WO PCT/US2007/079076 patent/WO2008036843A2/en active Application Filing
- 2007-09-20 CA CA002664411A patent/CA2664411A1/en not_active Abandoned
- 2007-09-20 JP JP2009529403A patent/JP5266232B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-19 TN TN2009000091A patent/TN2009000091A1/fr unknown
- 2009-03-19 IL IL197726A patent/IL197726A0/en unknown
- 2009-03-20 CO CO09029291A patent/CO6160324A2/es unknown
- 2009-03-31 NO NO20091331A patent/NO20091331L/no not_active Application Discontinuation
- 2009-04-02 MA MA31756A patent/MA30775B1/fr unknown
- 2009-11-17 HK HK09110735.0A patent/HK1131058A1/xx not_active IP Right Cessation
-
2010
- 2010-10-26 US US12/912,367 patent/US20110098247A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TN2009000091A1 (en) | 2010-08-19 |
| CA2664411A1 (en) | 2008-03-27 |
| EP2094272B1 (de) | 2014-03-26 |
| WO2008036843A3 (en) | 2008-05-15 |
| EP2094272A2 (de) | 2009-09-02 |
| MA30775B1 (fr) | 2009-10-01 |
| IL197726A0 (en) | 2009-12-24 |
| JP5266232B2 (ja) | 2013-08-21 |
| JP2010504357A (ja) | 2010-02-12 |
| US20080132499A1 (en) | 2008-06-05 |
| NZ576162A (en) | 2012-03-30 |
| US20110098247A1 (en) | 2011-04-28 |
| CO6160324A2 (es) | 2010-05-20 |
| AU2007299723A1 (en) | 2008-03-27 |
| US7834023B2 (en) | 2010-11-16 |
| BRPI0718444A2 (pt) | 2013-11-19 |
| RU2009114827A (ru) | 2010-10-27 |
| MX2009003017A (es) | 2009-06-08 |
| NO20091331L (no) | 2009-05-20 |
| WO2008036843A2 (en) | 2008-03-27 |
| KR20090057314A (ko) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200808966B (en) | Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors | |
| IL193482A0 (en) | Hydantoin based kinase inhibitors | |
| PT2402319T (pt) | Inibidores de dgat | |
| IL198171A0 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
| IL195010A0 (en) | Bicyclic derivatives as cetp inhibitors | |
| HK1133650A1 (en) | Hydantoin derivatives used as mmp inhibitors | |
| IL189194A0 (en) | Substituted benzimidazoles as kinase inhibitors | |
| PL2094263T3 (pl) | Pochodne 2-adamantylo-butyroamidowe jako selektywne inhibitory 11beta-HSD1 | |
| HK1133641A1 (zh) | 激酶抑製劑化合物 | |
| IL198487A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
| EP2200436A4 (de) | Substituierte pyrimidinylamine als proteinkinasenhemmer | |
| HK1163677A1 (zh) | 可用作激酶抑制劑的吡唑基氨基吡啶衍生物 | |
| EP2132211A4 (de) | 4-cyanphenylamino-substituierte bizyklische und heterozyklische verbindungen als hiv-hemmer | |
| ZA200808599B (en) | 4-anilinoquinoline-3-carboxamides as CSF-1R kinase inhibitors | |
| HK1131058A1 (en) | Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors | |
| IL198398A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
| IL198462A0 (en) | Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors | |
| IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
| IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
| ZA200800506B (en) | Substituted benzimidazoles as kinase inhibitors | |
| ZA200810573B (en) | Substituted 3-cyanopyridines as protein kinase inhibitors | |
| ZA200902082B (en) | Nitrogen containing substituted heterocycles as platelet ADP receptor inhibitors | |
| IL197981A0 (en) | Kinase inhibitors | |
| ZA200806993B (en) | Hydantoin based kinase inhibitors | |
| EP1998776A4 (de) | Pyridinhaltige makroheterocyclische verbindungen als kinasehemmer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190927 |